Erschienen in:
14.06.2022 | Clinical trial
Stalled at the intersection: insurance status and disparities in post-mastectomy breast reconstruction
verfasst von:
Orli Friedman-Eldar, Jonathan Burke, Iago de Castro Silva, Camille C. Baumrucker, Fernando Valle, Anne-Sophie Lessard, Wrood Kassira, Dido Franceschi, Susan B. Kesmodel, Eli Avisar, Neha Goel, Mecker G. Möller
Erschienen in:
Breast Cancer Research and Treatment
|
Ausgabe 2/2022
Einloggen, um Zugang zu erhalten
Abstract
Purpose
Post-mastectomy breast reconstruction (PMBR) is an important component of breast cancer treatment, but disparities relative to insurance status persist despite legislation targeting the issue. We aimed to study this relationship in a large health system combining a safety-net hospital and a private academic center.
Methods
Data were collected on all patients who underwent mastectomy for breast cancer from 2011 to 2019 in a private academic center and an adjacent public safety-net hospital served by the same surgical teams. Multivariable logistic regression was used to assess the effect of insurance status on PMBR, controlling for covariates that included socioeconomic, demographic, and clinical factors.
Results
Of 1554 patients undergoing mastectomy for breast cancer, 753 (48.5%) underwent PMBR, of which 592 (79.9%) were privately insured, 50 (6.7%) Medicare, 68 (9.2%) Medicaid, and 31 (4.2%) uninsured. Multivariable logistic regression showed a significantly higher likelihood of not undergoing PMBR for uninsured (OR 6.0, 95% CI 3.7–9.8; p < 0.0001), Medicare (OR 1.9, (95% CI 1.2–3.0; p = 0.006), and Medicaid (OR 1.5, 95% CI 1.0–2.3; p = 0.04) patients compared with privately insured patients. Age, stage, race and ethnicity, and hospital type confounded this relationship.
Conclusion
Patients without health insurance have dramatically reduced access to PMBR compared to those with private insurance. Expanding access to this important procedure is essential to achieve greater health equity for breast cancer patients.